| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327635 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
Macroscopically complete surgical cytoreduction significantly improves further survival of recurrent ovarian cancer patients. However, we remain in need to evaluate the debulkability of tumor before surgery to maximize the survival benefit and minimize the number of ineffective surgeries.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mete Güngör, Fırat Ortaç, Macit Arvas, Derin Kösebay, Murat Sönmezer, Kenan Köse,